Table of Content




1. Executive Summary


2. Global Advanced Therapy Medicinal Products Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Advanced Therapy Medicinal Products Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Advanced Therapy Medicinal Products Market by Product
3.3.1: Cell Therapy
3.3.2: CAR-T Therapy
3.3.3: Gene Therapy
3.3.4: Tissue Engineered Product



4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Advanced Therapy Medicinal Products Market by Region
4.2: North American Advanced Therapy Medicinal Products Market

4.3: European Advanced Therapy Medicinal Products Market
4.3.1: European Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product

4.4: APAC Advanced Therapy Medicinal Products Market
4.4.1: APAC Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product

4.5: ROW Advanced Therapy Medicinal Products Market
4.5.1: ROW Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Advanced Therapy Medicinal Products Market by Product


6.1.2: Growth Opportunities for the Global Advanced Therapy Medicinal Products Market by Region

6.2: Emerging Trends in the Global Advanced Therapy Medicinal Products Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Advanced Therapy Medicinal Products Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Advanced Therapy Medicinal Products Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Spark Therapeutics
7.2: Bluebird Bio
7.3: Novartis
7.4: UniQure
7.5: Celgene Corporation
7.6: Gilead Lifesciences
7.7: Kolon TissueGene
7.8: JCR Pharmaceuticals
7.9: MEDIPOST
7.10: Vericel Corporation